A Grandmother's Wisdom Shared

Gary Springer & Ethel Levine

Words of Reflection and Guidance of a 101-year old Woman

Don’t you wish you didn’t have to learn life’s lessons the hard way?

— Gary Springer

NEW YORK, NEW YORK, USA, September 30, 2017 /EINPresswire.com/ — FOR IMMEDIATE RELEASE

Wisdom of a Life Well-Lived
by Ethel Pearson Levine
A “must read” for seniors
Contact: Gary Springer
100 High Ridge Circle, San Marcos, TX 78666
512-396-8962
gjspring@aol.com
Don’t you wish you didn’t have to learn life’s lessons the hard way?
Beloved school teacher and guidance counselor, Ethel Pearson Levine, lived to age 101.

Over a period of 30 years, she wrote monthly articles for the Sunrise Lakes community in Fort Lauderdale, Florida. Her articles embrace universal subjects from marriage and divorce to relationships, aging, and death. She took on subjects that affect us all. Within each article, there’s a message, an affirmation, for living a meaningful life. This book is a collection of selected articles from that monthly news magazine, edited by her grandson,
Gary Springer. Available at:
https://store.bookbaby.com/book/Wisdom-of-a-Life-Well-Lived

“I just finished reading the book. I loved it and found it so inspiring. Your grandmother and my 2nd grade teacher was one very special lady.
A ‘must read’ for all seniors.”
– Sherry Koslov, former student

Ethel Levine was a wonderful teacher. I loved her. She was very kind. I had a problem in 2nd grade. I became very nearsighted and couldn't see the board. She would let me come up to the front to copy my work. She tested my eyes and found out I needed glasses. It changed my life.”

– Judy Lerner Cohen, former student
Hardcover ISBN: 9780692754269
E-book: 9781483578118

Hardcover; $25.65 each, E-book; $9.99

Dr. Gary Springer
Springer Counseling
512-754-6175
email us here


Source: EIN Presswire

The 1Heart Success and Continuing Professional Education Translates To Its Exceptional Growth in the US

Belina C. Nernberg (5th from right) along with executives, management and staff from 1Heart franchise locations during the franchisee business conference held last September 8, 2017 at 1Heart corporate headquarters.

1Heart’s Franchisee 3rd Qtr. Business Academy Training showed a strong, growing franchise with reinforced synergy among seasoned and new 1Heart business owners.

1Heart has so far been very successful and has experienced steady growth since the company started franchising few years ago.”

— Randolph Clarito

LOS ANGELES, CA, UNITED STATES, September 29, 2017 /EINPresswire.com/ — Leaders of various 1Heart franchise locations such as Los Angeles County, Ventura County, and some out of State converged at 1Heart's Corporate Headquarters last September 8, 2017 to form improved business strategies that would benefit 1Heart’s further success in the home care industry. The meeting was led by its CEO/Founder, Belina C. Nernberg and Director of Business and Franchise Development, Randolph Clarito.

The Business Conference focused on: Becoming an Effective and Successful Franchisee by doing business the 1Heart way.  Continuing education and training on the business system and processes were conducted by the heads of the HR/Staffing, Marketing, Accounting and Sales Departments.  Some of the areas discussed were with regards to business revenue generation, senior care management and quality assurance. The Conference ended with the sharing of ideas and renewed commitment to grow the 1Heart Brand in all 1Heart Franchise offices.

“This meeting has been a showcase of great ideas from all of 1Heart and I’m glad that all our Franchisees are as committed as we are at Corporate to build our brand nationwide.  We are celebrating our 14th year of operating in this thriving senior care industry and our business model has proven to be successful and effective. This is evident with our franchise locations that have shown increased revenue as they offer 1Heart’s services to more seniors in their respective areas.  It’s really great to know that 1Heart keeps getting better year after year. It is a winning culture.” says Belina.

“This kind of industry as with other businesses is ever changing. 1Heart has so far been very successful and has experienced steady growth since the company started franchising a few years ago. This success has enabled us to continue our expansion. In fact, we are currently offering franchise locations in the following states of Texas, Arizona, Colorado, New Mexico, Utah, Nevada, and California. And although we have received accolades here and there, we do not rest on our laurels and continue to innovate and adapt to the ever-changing market. We continue to improve on what we already have established and have executed programs and campaigns that helped us generate more increased visibility not only via traditional direct referral marketing and print but also, through online marketing such as website, social media, and email. Learning from the previous 2nd quarter Business Academy training on ’organizational effectiveness’, I am very glad that our franchise locations are implementing these programs and constantly finding other ways and means to further grow their 1Heart franchise office. I can say that this business conference has truly been very beneficial for the whole 1Heart to dominate, innovate and expand in the coming years. This is definitely something to look forward to.” says Randolph.

About 1Heart Caregiver Services®

1Heart Caregiver Services®, 1Heartcares.com, is a premier senior care services company that provides professional private care duty to seniors and adults requiring assistance in their home and healthcare needs. 1Heart Caregiver Services is a Certified Member of the American Board of Home Care, CAHSAH (California Association for Health Services at Home), Los Angeles Chamber of Commerce, International Franchise Association and is accredited by BBB. 1Heart Caregiver Services offers its services in Los Angeles County, Orange County, Ventura County, Santa Barbara County area, and in West Las Vegas, Nevada.

Belina Calderon-Nernberg
1Heart Caregiver Services
8053388100
email us here

The 1Heart Franchise Opportunity


Source: EIN Presswire

Houston Celebrates Corporate Wellness at 2017 Fall Fit Company Challenge

Teams from companies in Houston show the impact of their wellness programs by training for and conquering a 3-course fitness challenge hosted by Fit Company.

HOUSTON, TEXAS, USA, September 29, 2017 /EINPresswire.com/ — On September 16, 2017 participants from companies located in the Houston Texas area took part in the Fit Company Challenge, a corporate wellness event hosted by the Fit Company Institute. The challenge provided area companies an opportunity to come together as a team and spend a morning exercising, pushing their physical and mental limits and showing the importance of living a healthy lifestyle. Companies split their team into squads of 3 to 4 people who worked together to complete a variety of fitness stations to challenge their fitness level and earn points for their company. Teams chose what level to go through each course which allowed participants of all fitness levels to push their physical fitness without going too far out of their comfort zone.

For the 1st Fall Challenge in Houston PinnacleART took the top spot in the Large Division. From PinnacleART’s team captain Lindsay Carter, “The Fit Company Challenge was a physically and mentally demanding experience that highlighted new exercises that we as individuals can incorporate into our fit lifestyle. In our small teams, we were able to meet new people within the company and build camaraderie. Overall, it was a wonderful way to see the efforts of our Workplace Wellness committee come to life and make a real impact on our employees’ lifestyle and morale.”

In their 3rd year participating, Walker Elliott came out stronger then ever and took 1st place in the Small team division. From team captain Marianne Thai “Walker Elliott has participated in this event for the past 3 years, and every year we come back stronger and better prepared. We're up to 60% of employee participation who have trained and competed. We train together as a team and encourage healthier eating regimens, which has led to overall healthier lifestyles for everyone. We look forward to participating again in the Spring!”

On event date, volunteers assisted the contenders through the courses from Texas State Department of Health and Human Performance, and RightFit Personal Training (www.rightfitpersonaltraining.com). Participants challenged their strength, conditioning, power, agility, and ended with a test of endurance to show their companies and colleagues that they practice what they preach. Participants used their involvement to bring out company team members, and family members to cheer them on and promote the importance of having fun and effective corporate wellness programs at their companies.

The challenge was held at Houston Sports Park, close to downtown Houston.

The following is a list of the top finishers in Houston that participated in the 2017 Fit Company Challenge:

Top Companies by Division

Large Division
1) PinnacleART
2) Bray International, Inc.

Small Division
1) Walker Elliott LP
2) KorMex Foods

Micro Division
1) Mitsui E&P USA LLC
2) Global Healing Center

Top Teams By Course

Course 1 – Level 2

1) Bray International, Inc. – #1443
– Tom McGonigle
– Ron Veillon
– Evandro Felice
– Zachry Brown
2) Bray International, Inc. – #1444
– Darin Carlson
– Eduardo Cerri
– Jose Marquez
– Shahrum Iqball
3) Mitsui E&P USA LLC – #1459
– Willie Vera
– Greg Jallans
– Jeremy Orr
– Hirotake Tsunooka
4) Bray International, Inc. – #1445
– Emerson Ramos
– Joel Ferman
– Marco Torres

Course 1 – Level 1

1) Walker Elliott LP – #1448
– Marianne Thai
– Marcques Bridges
– Lisa McCowan
2) Walker Elliott LP – #1450
– Jennafer Payne
– Ali Faye
– Amanda Hayes
– Alana Vorda
3) Walker Elliott LP – #1449
– Hudson Chen
– Neerav Parikh
– Diana Lee
4) Bray International, Inc. – #1447 (Tie)
– Haley Ferner
– Joceyln Canas
– Cristina Pineda
4) PinnacleART – #1453 (Tie)
– Julian Parra
– Shawn Lester
– Kate Cammarata
– Sidney Sherrill

Course 2 – Level 2

1) Bray International, Inc. – #1444
– Darin Carlson
– Eduardo Cerri
– Jose Marquez
– Shahrum Iqball
2) Bray International, Inc. – #1443
– Tom McGonigle
– Ron Veillon
– Evandro Felice
– Zachry Brown
3) Mitsui E&P USA LLC – #1459
– Willie Vera
– Greg Jallans
– Jeremy Orr
– Hirotake Tsunooka
4) PinnacleART – #1456
– Stew Pinckard
– Jerod Aragon
– Christian Flores
– Lauren Ryan

Course 2 – Level 1

1) Walker Elliott LP – #1448
– Marianne Thai
– Marcques Bridges
– Lisa McCowan
2) PinnacleART – #1453
– Julian Parra
– Shawn Lester
– Kate Cammarata
– Sidney Sherrill
3) PinnacleART – #1451
– Joey Rappaport
– CJ Anyigbo
– Lauren Kretsch
– Raji Athuru
4) PinnacleART – #1452
– Raymond Weir
– Travis Gaston
– Emily Cashi
– Anglia Lindsay

Course 3 – Level 2

1) PinnacleART – #1456
– Stew Pinckard
– Jerod Aragon
– Christian Flores
– Lauren Ryan
2) Bray International, Inc. – #1444 (Tie)
– Darin Carlson
– Eduardo Cerri
– Jose Marquez
– Shahrum Iqball
2) Bray International, Inc. – #1446 (Tie)
– Nipun Nanayakkara
– Ross Eppinette
– Jeremy Mercier
– Patrick O'Connell
4) Bray International, Inc. – #1443
– Tom McGonigle
– Ron Veillon
– Evandro Felice
– Zachry Brown

Course 3 – Level 1

1) KorMex Foods – #1440 (Tie)
– Steve Sula
– Roman Karabanov
– Alejandro Limas
– Chad Motsinger
1) PinnacleART – #1453 (Tie)
– Julian Parra
– Shawn Lester
– Kate Cammarata
– Sidney Sherrill
1) PinnacleART – #1457 (Tie)
– Rae Covington
– Sammi Patel
– Chris Asumnu
4) Walker Elliott LP – #1448 (Tie)
– Marianne Thai
– Marcques Bridges
– Lisa McCowan
4) PinnacleART – #1451 (Tie)
– Joey Rappaport
– CJ Anyigbo
– Lauren Kretsch
-Raji Athuru
4) Mitsui E&P USA LLC – #1459 (Tie)
– Willie Vera
– Greg Jallans
– Jeremy Orr
– Hirotake Tsunooka

About the Fit Company Institute:

The Fit Company Institute is based in Austin, Texas and is dedicated to help companies thrive through wellness. The Fit Company Challenge helps companies be their best by creating the most productive, focused, energetic, happiest, and cohesive teams possible.

Find more at www.fitcompany.com and upcoming events in cities across the US.

Matt Barker
Fit Company Institute
888-994-9964
email us here


Source: EIN Presswire

New Master Data Management Solution Helps Small to Mid-size Pharmaceutical Companies Better Manage Data

Affordable Solution Makes Pharmaceutical Master Data Management Easier

For me, ATMaster is a lifesaver; it’s easy to query, to merge records, and manage addresses. It is also highly automated, which is important for a small shop.”

— Senior Director, Sales Operations

PENNINGTON, NJ, USA, September 29, 2017 /EINPresswire.com/ — Archi-Tech Systems, Inc. (ATSI) has announced the latest release of ATMaster, a scalable, cost-effective MDM solution for small-to-medium-sized pharma. ATMaster is an on-line, client-proprietary repository of customer data that allows companies to distill, customize, and reconcile customer information from multiple sources. With it, clients can standardize reporting, feed data governance initiatives, and integrate datasets to deliver 360-degree customer views.

“ATMaster is the perfect small company MDM,” said Paul Gray, ATSI President, “Our clients were struggling to link a growing number of data silos, so we developed a right-sized, flexible MDM solution to assist with this critical integration problem.”

ATMaster is already in place at several customers. A Senior Director, Sales Operations, states:
“For me, ATMaster is a lifesaver; it’s easy to query, to merge records, and manage addresses. It is also highly automated, which is important for a small shop. ATSI handles all of my data management; and when other vendors try to compete for my overall business, I always ask who is going to take care of my universe – and our discussion stops there, because their MDM solutions are non-existent or overkill.”

ATMaster includes all the must-haves in a straightforward, intuitive system:

– Self-Running Environment. Automated processing, business-rule based exception handling, and pre-scheduled feeds into reporting systems.
– Helps Resolve Major Challenges, including address management, address standardization, duplicates, etc.
– Client Custom Profiles, including client-defined segmentations, classes of trade, and groups.
– Client-Confidential. Secure, dedicated cloud server.
– All Customer Types. In addition to prescribers, it can pull in all customer data: Ex-factory Direct Customers, Wholesaler 867 Accounts, Chargebacks, SFA, Syndicated and SPP Rx, Co-Pay/Coupon Redemptions, etc.
– NPI Insights. Embedded NPI universe, for linking NPI IDs, group practice information, Sunshine Reporting, and ongoing marketing analysis.
– Analyst Support Services, for assisting in resolving exceptions, duplicates resolution, and field inquiries.

Adds Paul: “Our clients stated that using their SFA or data vendor was both cost-prohibitive and limiting. They needed the flexibility to change vendors, and mix datasets from competing vendors without worry.“

About: Archi-Tech (http://www.Archi-Tech.com) is a leading provider of outsourced data integration, analytics and reporting services to the Pharmaceuticals Industry. Over the past 25 years we have delivered custom solutions to over 100 companies, ranging from start-ups to established industry giants. We platform your commercial operations data and from that platform create actionable intelligence giving you a 360° view of your world to help you better manage your business.

Gordon Filepas
Archi-Tech Systems, Inc.
609-963-4065
email us here


Source: EIN Presswire

Radiotherapy Equipments Market 2017 Global Industry Key Players, Share, Trend, Segmentation and Forecast to 2022

Radiotherapy Equipments Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022

PUNE, INDIA, September 29, 2017 /EINPresswire.com/ — Radiotherapy Equipments Market 2017

Wiseguyreports.Com adds “Radiotherapy Equipments Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022” To Its Research Database.

Report Details:

This report provides in depth study of “Radiotherapy Equipments Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Radiotherapy Equipments Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies Radiotherapy Equipments in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering 
Varian Medical Systems 
Elekta AB 
Accuray Incorporated 
IBA (Ion Beam Applications Sa) 
Nordion 
C. R. Bard 
Isoray Medical 
Raysearch Laboratories AB 
Mevion Medical Systems 
Mitsubishi Electric

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1644871-global-radiotherapy-equipments-market-professional-survey-report-2017

By types, the market can be split into 
External Beam Radiotherapy Equipments 
Internal Beam Radiotherapy Equipments 
Systemic Radiotherapy Equipments

By Application, the market can be split into 
Hospitals 
Ambulatory Radiotherapy Centers 
Cancer Research Institutes

By Regions, this report covers (we can add the regions/countries as you want) 
North America 
China 
Europe 
Southeast Asia 
Japan 
India

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/1644871-global-radiotherapy-equipments-market-professional-survey-report-2017

Major Key Points in Table of Content:

1 Industry Overview of Radiotherapy Equipments 
1.1 Definition and Specifications of Radiotherapy Equipments 
1.1.1 Definition of Radiotherapy Equipments 
1.1.2 Specifications of Radiotherapy Equipments 
1.2 Classification of Radiotherapy Equipments 
1.2.1 External Beam Radiotherapy Equipments 
1.2.2 Internal Beam Radiotherapy Equipments 
1.2.3 Systemic Radiotherapy Equipments 
1.3 Applications of Radiotherapy Equipments 
1.3.1 Hospitals 
1.3.2 Ambulatory Radiotherapy Centers 
1.3.3 Cancer Research Institutes 
1.4 Market Segment by Regions 
1.4.1 North America 
1.4.2 China 
1.4.3 Europe 
1.4.4 Southeast Asia 
1.4.5 Japan 
1.4.6 India
….

4 Global Radiotherapy Equipments Overall Market Overview 
4.1 2012-2017E Overall Market Analysis 
4.2 Capacity Analysis 
4.2.1 2012-2017E Global Radiotherapy Equipments Capacity and Growth Rate Analysis 
4.2.2 2016 Radiotherapy Equipments Capacity Analysis (Company Segment) 
4.3 Sales Analysis 
4.3.1 2012-2017E Global Radiotherapy Equipments Sales and Growth Rate Analysis 
4.3.2 2016 Radiotherapy Equipments Sales Analysis (Company Segment) 
4.4 Sales Price Analysis 
4.4.1 2012-2017E Global Radiotherapy Equipments Sales Price 
4.4.2 2016 Radiotherapy Equipments Sales Price Analysis (Company Segment)
….

8 Major Manufacturers Analysis of Radiotherapy Equipments 
8.1 Varian Medical Systems 
8.1.1 Company Profile 
8.1.2 Product Picture and Specifications 
8.1.2.1 Product A 
8.1.2.2 Product B 
8.1.3 Varian Medical Systems 2016 Radiotherapy Equipments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.1.4 Varian Medical Systems 2016 Radiotherapy Equipments Business Region Distribution Analysis 
8.2 Elekta AB 
8.2.1 Company Profile 
8.2.2 Product Picture and Specifications 
8.2.2.1 Product A 
8.2.2.2 Product B 
8.2.3 Elekta AB 2016 Radiotherapy Equipments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.2.4 Elekta AB 2016 Radiotherapy Equipments Business Region Distribution Analysis 
8.3 Accuray Incorporated 
8.3.1 Company Profile 
8.3.2 Product Picture and Specifications 
8.3.2.1 Product A 
8.3.2.2 Product B 
8.3.3 Accuray Incorporated 2016 Radiotherapy Equipments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.3.4 Accuray Incorporated 2016 Radiotherapy Equipments Business Region Distribution Analysis 
8.4 IBA (Ion Beam Applications Sa) 
8.4.1 Company Profile 
8.4.2 Product Picture and Specifications 
8.4.2.1 Product A 
8.4.2.2 Product B 
8.4.3 IBA (Ion Beam Applications Sa) 2016 Radiotherapy Equipments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.4.4 IBA (Ion Beam Applications Sa) 2016 Radiotherapy Equipments Business Region Distribution Analysis 
8.5 Nordion 
8.5.1 Company Profile 
8.5.2 Product Picture and Specifications 
8.5.2.1 Product A 
8.5.2.2 Product B 
8.5.3 Nordion 2016 Radiotherapy Equipments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.5.4 Nordion 2016 Radiotherapy Equipments Business Region Distribution Analysis 
8.6 C. R. Bard 
8.6.1 Company Profile 
8.6.2 Product Picture and Specifications 
8.6.2.1 Product A 
8.6.2.2 Product B 
8.6.3 C. R. Bard 2016 Radiotherapy Equipments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.6.4 C. R. Bard 2016 Radiotherapy Equipments Business Region Distribution Analysis 
8.7 Isoray Medical 
8.7.1 Company Profile 
8.7.2 Product Picture and Specifications 
8.7.2.1 Product A 
8.7.2.2 Product B 
8.7.3 Isoray Medical 2016 Radiotherapy Equipments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.7.4 Isoray Medical 2016 Radiotherapy Equipments Business Region Distribution Analysis 
8.8 Raysearch Laboratories AB 
8.8.1 Company Profile 
8.8.2 Product Picture and Specifications 
8.8.2.1 Product A 
8.8.2.2 Product B 
8.8.3 Raysearch Laboratories AB 2016 Radiotherapy Equipments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.8.4 Raysearch Laboratories AB 2016 Radiotherapy Equipments Business Region Distribution Analysis 
8.9 Mevion Medical Systems 
8.9.1 Company Profile 
8.9.2 Product Picture and Specifications 
8.9.2.1 Product A 
8.9.2.2 Product B 
8.9.3 Mevion Medical Systems 2016 Radiotherapy Equipments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.9.4 Mevion Medical Systems 2016 Radiotherapy Equipments Business Region Distribution Analysis 
8.10 Mitsubishi Electric 
8.10.1 Company Profile 
8.10.2 Product Picture and Specifications 
8.10.2.1 Product A 
8.10.2.2 Product B 
8.10.3 Mitsubishi Electric 2016 Radiotherapy Equipments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.10.4 Mitsubishi Electric 2016 Radiotherapy Equipments Business Region Distribution Analysis

Continued….

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1644871

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Diaper Market 2017 Segmentation, Demand, Growth, Trend, Opportunity and Forecast to 2022

Wiseguyreports.Com Adds “Diaper-Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database.

PUNE, INDIA, September 29, 2017 /EINPresswire.com/ — Diaper Market 2017 

Description: 

This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Diaper industry.

This report splits Diaper market By Material, By Shape, which covers the history data information from 2012 to 2016 and forecast from 2017 to 2022.

This report focuses Global market, it covers details as following:

Major Companies: 
P&G (U.S.) 
Kimberly Clark (U.S.) 
Hengan (China) 
KAO (Japan) 
Unicharm (Japan) 
SCA (U.S.) 
Philips Healthcare (U.S.) 
Associated Hygienic (U.S.) 
Cotton Babies (U.S.) 
Drylok (U.S.) 
First Quality (U.S.) 
Ontex (Belgium) 
OsoCozy (U.S.) 
Seventh Generation (U.S.) 
Hain Celestial (U.S.) 
The Honest Co. (U.S.)

Request for Sample Report@ https://www.wiseguyreports.com/sample-request/2353220-global-diaper-detailed-analysis-report-2017-2022

Main Regions: 
North America 
United States 
Canada 
Latin America 
Mexico 
Brazil 
Argentina 
Others 
Europe 
Germany 
United Kingdom 
France 
Italy 
Spain 
Russia 
Netherland 
Others 
Asia & Pacific 
China 
Japan 
India 
Korea 
Australia 
Southeast Asia 
Indonesia 
Thailand 
Philippines 
Vietnam 
Singapore 
Malaysia 
Others 
Africa & Middle East 
South Africa 
Egypt 
Turkey 
Saudi Arabia 
Iran 
Others

Main Product Type: 
Diaper Market, by Material 
Cotton 
Hemp 
Modal 
Polyester 
Others 
Diaper Market, by Shape 
Disposable 
Cloth Diaper 
Pocket Diaper 
Others

Main Applications: 
Specialist Retailers 
Supermarket 
Internet Sales 
Others

Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/2353220-global-diaper-detailed-analysis-report-2017-2022

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents:

Global Diaper Detailed Analysis Report 2017-2022 
Chapter One Diaper Market Overview 
1.1 Global Diaper Market Sales Volume Revenue and Price 2012-2022 
1.2 Diaper, By Material 2012-2022 
1.2.1 Global Diaper Sales Market Share by Material 2012-2022 
1.2.2 Global Diaper Revenue Market Share by Material 2012-2022 
1.2.3 Global Diaper Price by Material 2012-2022 
1.2.4 Cotton 
1.2.5 Hemp 
1.2.6 Modal 
1.2.7 Polyester 
1.2.8 Others 
1.3 Diaper, by Shape 2012-2022 
1.3.1 Global Diaper Sales Market Share by Shape 2012-2022 
1.3.2 Global Diaper Revenue Market Share by Shape 2012-2022 
1.3.3 Global Diaper Price by Shape 2012-2022 
1.3.4 Disposable 
1.3.5 Cloth Diaper 
1.3.6 Pocket Diaper 
1.3.7 Others

Chapter Three Diaper by Players 2012-2017 
3.1 Global Diaper Sales Volume Market Share by Players 2012-2017 
3.2 Global Diaper Revenue Share by Players 2012-2017 
3.3 Global Top Players Diaper Key Product Model and Market Performance 
3.4 Global Top Players Diaper Key Target Consumers and Market Performance

…….

Chapter Five Global Top Players Profile 
5.1 P&G (U.S.) 
5.1.1 P&G (U.S.) Company Details and Competitors 
5.1.2 P&G (U.S.) Key Diaper Models and Performance 
5.1.3 P&G (U.S.) Diaper Business SWOT Analysis and Forecast 
5.1.4 P&G (U.S.) Diaper Sales Volume Revenue Price Cost and Gross Margin 
5.2 Kimberly Clark (U.S.) 
5.2.1 Kimberly Clark (U.S.) Company Details and Competitors 
5.2.2 Kimberly Clark (U.S.) Key Diaper Models and Performance 
5.2.3 Kimberly Clark (U.S.) Diaper Business SWOT Analysis and Forecast 
5.2.4 Kimberly Clark (U.S.) Diaper Sales Volume Revenue Price Cost and Gross Margin 
5.3 Hengan (China) 
5.3.1 Hengan (China) Company Details and Competitors 
5.3.2 Hengan (China) Key Diaper Models and Performance 
5.3.3 Hengan (China) Diaper Business SWOT Analysis and Forecast 
5.3.4 Hengan (China) Diaper Sales Volume Revenue Price Cost and Gross Margin 
5.4 KAO (Japan) 
5.4.1 KAO (Japan) Company Details and Competitors 
5.4.2 KAO (Japan) Key Diaper Models and Performance 
5.4.3 KAO (Japan) Diaper Business SWOT Analysis and Forecast 
5.4.4 KAO (Japan) Diaper Sales Volume Revenue Price Cost and Gross Margin 
5.5 Unicharm (Japan) 
5.5.1 Unicharm (Japan) Company Details and Competitors 
5.5.2 Unicharm (Japan) Key Diaper Models and Performance 
5.5.3 Unicharm (Japan) Diaper Business SWOT Analysis and Forecast 
5.5.4 Unicharm (Japan) Diaper Sales Volume Revenue Price Cost and Gross Margin 
5.6 SCA (U.S.) 
5.6.1 SCA (U.S.) Company Details and Competitors 
5.6.2 SCA (U.S.) Key Diaper Models and Performance 
5.6.3 SCA (U.S.) Diaper Business SWOT Analysis and Forecast 
5.6.4 SCA (U.S.) Diaper Sales Volume Revenue Price Cost and Gross Margin 
5.7 Philips Healthcare (U.S.) 
5.7.1 Philips Healthcare (U.S.) Company Details and Competitors 
5.7.2 Philips Healthcare (U.S.) Key Diaper Models and Performance 
5.7.3 Philips Healthcare (U.S.) Diaper Business SWOT Analysis and Forecast 
5.7.4 Philips Healthcare (U.S.) Diaper Sales Volume Revenue Price Cost and Gross Margin 
5.8 Associated Hygienic (U.S.) 
5.8.1 Associated Hygienic (U.S.) Company Details and Competitors 
5.8.2 Associated Hygienic (U.S.) Key Diaper Models and Performance 
5.8.3 Associated Hygienic (U.S.) Diaper Business SWOT Analysis and Forecast 
5.8.4 Associated Hygienic (U.S.) Diaper Sales Volume Revenue Price Cost and Gross Margin 
5.9 Cotton Babies (U.S.) 
5.9.1 Cotton Babies (U.S.) Company Details and Competitors 
5.9.2 Cotton Babies (U.S.) Key Diaper Models and Performance 
5.9.3 Cotton Babies (U.S.) Diaper Business SWOT Analysis and Forecast 
5.9.4 Cotton Babies (U.S.) Diaper Sales Volume Revenue Price Cost and Gross Margin 
5.10 Drylok (U.S.) 
5.10.1 Drylok (U.S.) Company Details and Competitors 
5.10.2 Drylok (U.S.) Key Diaper Models and Performance 
5.10.3 Drylok (U.S.) Diaper Business SWOT Analysis and Forecast 
5.10.4 Drylok (U.S.) Diaper Sales Volume Revenue Price Cost and Gross Margin 
5.11 First Quality (U.S.) 
5.12 Ontex (Belgium) 
5.13 OsoCozy (U.S.) 
5.14 Seventh Generation (U.S.) 
5.15 Hain Celestial (U.S.) 
5.16 The Honest Co. (U.S.)

Continued…..

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2353220

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Bio-pharmaceuticals Market 2017 Share, Trend, Segmentation And Forecast To 2022

Bio-pharmaceuticals -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022

PUNE , MAHARASHTRA, INDIA, September 29, 2017 /EINPresswire.com/ — Bio-pharmaceuticals Industry

Description

Wiseguyreports.Com Adds “Bio-pharmaceuticals -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022” To Its Research Database

Bio-pharmaceuticals Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom,Japan, South Korea and China).

In this report, the global Bio-pharmaceuticals market is valued at USD XX million in 2017 and is projected to reach USD XX million by the end of 2021, growing at a CAGR of XX% during the period 2017 to 2021.

The report firstly introduced the Bio-pharmaceuticals basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include: 

Baxalta 
Fujifilm Diosynth 
Foamix Pharmaceuticals 
Company D 
Primeast 
Company F 
……

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2303151-global-bio-pharmaceuticals-market-report-and-forecast-to-2021

The end users/applications and product categories analysis: 
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into- 
Vaccines 
Gene therapy 
Biosimilars 
……

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Bio-pharmaceuticals for each application, including- 
Medical use 
Application B 
Others

Leave a Query @ https://www.wiseguyreports.com/enquiry/2303151-global-bio-pharmaceuticals-market-report-and-forecast-to-2021

Table of Contents

Part I Bio-pharmaceuticals Industry Overview

Chapter One Bio-pharmaceuticals Industry Overview 
    1.1 Bio-pharmaceuticals Definition 
    1.2 Bio-pharmaceuticals Classification Analysis 
Vaccines 
Gene therapy 
Biosimilars 
…… 
      1.2.1 Bio-pharmaceuticals Main Classification Analysis 
      1.2.2 Bio-pharmaceuticals Main Classification Share Analysis 
    1.3 Bio-pharmaceuticals Application Analysis 
Medical use 
Application B 
Others 
…… 
      1.3.1 Bio-pharmaceuticals Main Application Analysis 
      1.3.2 Bio-pharmaceuticals Main Application Share Analysis 
    1.4 Bio-pharmaceuticals Industry Chain Structure Analysis 
    1.5 Bio-pharmaceuticals Industry Development Overview 
      1.5.1 Bio-pharmaceuticals Product History Development Overview 
      1.5.1 Bio-pharmaceuticals Product Market Development Overview 
    1.6 Bio-pharmaceuticals Global Market Comparison Analysis 
      1.6.1 Bio-pharmaceuticals Global Import Market Analysis 
      1.6.2 Bio-pharmaceuticals Global Export Market Analysis 
      1.6.3 Bio-pharmaceuticals Global Main Region Market Analysis 
      1.6.4 Bio-pharmaceuticals Global Market Comparison Analysis 
      1.6.5 Bio-pharmaceuticals Global Market Development Trend Analysis

Chapter Two Bio-pharmaceuticals Up and Down Stream Industry Analysis 
    2.1 Upstream Raw Materials Analysis 
      2.1.1 Upstream Raw Materials Price Analysis 
      2.1.2 Upstream Raw Materials Market Analysis 
      2.1.3 Upstream Raw Materials Market Trend 
    2.2 Down Stream Market Analysis 
      2.1.1 Down Stream Market Analysis 
      2.2.2 Down Stream Demand Analysis 
      2.2.3 Down Stream Market Trend Analysis

Part II Asia Bio-pharmaceuticals Industry (The Report Company Including the Below Listed But Not All) 

Chapter Three Asia Bio-pharmaceuticals Market Analysis 
    3.1 Asia Bio-pharmaceuticals Product Development History 
    3.2 Asia Bio-pharmaceuticals Competitive Landscape Analysis 
    3.3 Asia Bio-pharmaceuticals Market Development Trend

Chapter Four 2012-2017 Asia Bio-pharmaceuticals Productions Supply Sales Demand Market Status and Forecast 
    4.1 2012-2017 Bio-pharmaceuticals Capacity Production Overview 
    4.2 2012-2017 Bio-pharmaceuticals Production Market Share Analysis 
    4.3 2012-2017 Bio-pharmaceuticals Demand Overview 
    4.4 2012-2017 Bio-pharmaceuticals Supply Demand and Shortage Analysis 
    4.5 2012-2017 Bio-pharmaceuticals Import Export Consumption Analysis 
    4.6 2012-2017 Bio-pharmaceuticals Cost Price Production Value Profit Analysis

Chapter Five Asia Bio-pharmaceuticals Key Manufacturers Analysis 
    5.1 Baxalta 
      5.1.1 Company Profile 
      5.1.2 Product Picture and Specification 
      5.1.3 Product Application Analysis 
      5.1.4 Capacity Production Price Cost Production Value Analysis 
      5.1.5 Contact Information 
    5.2 Fujifilm Diosynth 
      5.2.1 Company Profile 
      5.2.2 Product Picture and Specification 
      5.2.3 Product Application Analysis 
      5.2.4 Capacity Production Price Cost Production Value Analysis 
      5.2.5 Contact Information 
    5.3 Company C 
      5.3.1 Company Profile 
      5.3.2 Product Picture and Specification 
      5.3.3 Product Application Analysis 
      5.3.4 Capacity Production Price Cost Production Value Analysis 
      5.3.5 Contact Information 
… 
… 
Chapter Six Asia Bio-pharmaceuticals Industry Development Trend 
    6.1 2017-2021 Bio-pharmaceuticals Capacity Production Trend 
    6.2 2017-2021 Bio-pharmaceuticals Production Market Share Analysis 
    6.3 2017-2021 Bio-pharmaceuticals Demand Trend 
    6.4 2017-2021 Bio-pharmaceuticals Supply Demand and Shortage Analysis 
    6.5 2017-2021 Bio-pharmaceuticals Import Export Consumption Analysis 
    6.6 2017-2021 Bio-pharmaceuticals Cost Price Production Value Profit Analysis

Part III North American Bio-pharmaceuticals Industry (The Report Company Including the Below Listed But Not All) 

Chapter Seven North American Bio-pharmaceuticals Market Analysis 
    7.1 North American Bio-pharmaceuticals Product Development History 
    7.2 North American Bio-pharmaceuticals Competitive Landscape Analysis 
    7.3 North American Bio-pharmaceuticals Market Development Trend

Chapter Eight 2012-2017 North American Bio-pharmaceuticals Productions Supply Sales Demand Market Status and Forecast 
    8.1 2012-2017 Bio-pharmaceuticals Capacity Production Overview 
    8.2 2012-2017 Bio-pharmaceuticals Production Market Share Analysis 
    8.3 2012-2017 Bio-pharmaceuticals Demand Overview 
    8.4 2012-2017 Bio-pharmaceuticals Supply Demand and Shortage Analysis 
    8.5 2012-2017 Bio-pharmaceuticals Import Export Consumption Analysis 
    8.6 2012-2017 Bio-pharmaceuticals Cost Price Production Value Profit Analysis

Chapter Nine North American Bio-pharmaceuticals Key Manufacturers Analysis 
    9.1 Foamix Pharmaceuticals 
      9.1.1 Company Profile 
      9.1.2 Product Picture and Specification 
      9.1.3 Product Application Analysis 
      9.1.4 Capacity Production Price Cost Production Value Analysis 
      9.1.5 Contact Information 
    9.1 Company D 
      9.2.1 Company Profile 
      9.2.2 Product Picture and Specification 
      9.2.3 Product Application Analysis 
      9.2.4 Capacity Production Price Cost Production Value Analysis 
      9.2.5 Contact Information 
… 

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2303151

Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Diagnostic Imaging Product Portfolio Market 2017 Share, Trend, Segmentation And Forecast To 2021

Diagnostic Imaging Product Portfolio -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2021

PUNE , MAHARASHTRA, INDIA, September 29, 2017 /EINPresswire.com/ — Diagnostic Imaging Product Portfolio Industry

Description

Wiseguyreports.Com Adds “Diagnostic Imaging Product Portfolio -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2021” To Its Research Database

Diagnostic Imaging Product Portfolio Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom,Japan, South Korea and China).

In this report, the global Diagnostic Imaging Product Portfolio market is valued at USD XX million in 2017 and is projected to reach USD XX million by the end of 2021, growing at a CAGR of XX% during the period 2017 to 2021.

The report firstly introduced the Diagnostic Imaging Product Portfolio basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include: 
Fujifilm 
Toshiba 
GE Healthcare 
Analogic 
Siemens 
Philips 
……

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2303166-global-diagnostic-imaging-product-portfolio-market-size-and-forecast-to-2021

The end users/applications and product categories analysis: 
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into- 
MRI Systems 
Ultrasound Imaging Systems 
Nuclear Imaging Systems 
……

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Diagnostic Imaging Product Portfolio for each application, including- 
Hospital 
Lab 
Others

Leave a Query @ https://www.wiseguyreports.com/enquiry/2303166-global-diagnostic-imaging-product-portfolio-market-size-and-forecast-to-2021

Table of Contents

Part I Diagnostic Imaging Product Portfolio Industry Overview

Chapter One Diagnostic Imaging Product Portfolio Industry Overview 
    1.1 Diagnostic Imaging Product Portfolio Definition 
    1.2 Diagnostic Imaging Product Portfolio Classification and Product Type Analysis 
MRI Systems 
Ultrasound Imaging Systems 
Nuclear Imaging Systems 
…… 
    1.3 Diagnostic Imaging Product Portfolio Application and Down Stream Market Analysis 
Hospital 
Lab 
Others 
…… 
    1.4 Diagnostic Imaging Product Portfolio Industry Chain Structure Analysis 
    1.5 Diagnostic Imaging Product Portfolio Industry Development Overview 
    1.6 Diagnostic Imaging Product Portfolio Global Market Comparison Analysis 
      1.6.1 Diagnostic Imaging Product Portfolio Global Import Market Analysis 
      1.6.2 Diagnostic Imaging Product Portfolio Global Export Market Analysis 
      1.6.3 Diagnostic Imaging Product Portfolio Global Main Region Market Analysis 
      1.6.4 Diagnostic Imaging Product Portfolio Global Market Comparison Analysis 
      1.6.5 Diagnostic Imaging Product Portfolio Global Market Development Trend Analysis

Part II Asia Diagnostic Imaging Product Portfolio Industry (The Report Company Including the Below Listed But Not All)

Chapter Two 2012-2017 Asia Diagnostic Imaging Product Portfolio Productions Supply Sales Demand Market Status and Forecast 
    2.1 2012-2017 Diagnostic Imaging Product Portfolio Capacity Production Overview 
    2.2 2012-2017 Diagnostic Imaging Product Portfolio Production Market Share Analysis 
    2.3 2012-2017 Diagnostic Imaging Product Portfolio Demand Overview 
    2.4 2012-2017 Diagnostic Imaging Product Portfolio Supply Demand and Shortage Analysis 
    2.5 2012-2017 Diagnostic Imaging Product Portfolio Import Export Consumption Analysis 
    2.6 2012-2017 Diagnostic Imaging Product Portfolio Cost Price Production Value Profit Analysis

Chapter Three Asia Diagnostic Imaging Product Portfolio Key Manufacturers Analysis 
    3.1 Fujifilm 
      3.1.1 Product Picture and Specification 
      3.1.2 Capacity Production Price Cost Production Value Analysis 
      3.1.3 Contact Information

    3.2 Toshiba 
      3.2.1 Product Picture and Specification 
      3.2.2 Capacity Production Price Cost Production Value Analysis 
      3.2.3 Contact Information

    3.3 Company C 
      3.3.1 Product Picture and Specification 
      3.3.2 Capacity Production Price Cost Production Value Analysis 
      3.3.3 Contact Information 
… 
… 
Chapter Four Asia Diagnostic Imaging Product Portfolio Industry Development Trend 
    4.1 2017-2021 Diagnostic Imaging Product Portfolio Capacity Production Trend 
    4.2 2017-2021 Diagnostic Imaging Product Portfolio Production Market Share Analysis 
    4.3 2017-2021 Diagnostic Imaging Product Portfolio Demand Trend 
    4.4 2017-2021 Diagnostic Imaging Product Portfolio Supply Demand and Shortage Analysis 
    4.5 2017-2021 Diagnostic Imaging Product Portfolio Import Export Consumption Analysis 
    4.6 2017-2021 Diagnostic Imaging Product Portfolio Cost Price Production Value Profit Analysis

Part III North American Diagnostic Imaging Product Portfolio Industry (The Report Company Including the Below Listed But Not All)

Chapter Five 2012-2017 North American Diagnostic Imaging Product Portfolio Productions Supply Sales Demand Market Status and Forecast 
    5.1 2012-2017 Diagnostic Imaging Product Portfolio Capacity Production Overview 
    5.2 2012-2017 Diagnostic Imaging Product Portfolio Production Market Share Analysis 
    5.3 2012-2017 Diagnostic Imaging Product Portfolio Demand Overview 
    5.4 2012-2017 Diagnostic Imaging Product Portfolio Supply Demand and Shortage Analysis 
    5.5 2012-2017 Diagnostic Imaging Product Portfolio Import Export Consumption Analysis 
    5.6 2012-2017 Diagnostic Imaging Product Portfolio Cost Price Production Value Profit Analysis

Chapter Six North American Diagnostic Imaging Product Portfolio Key Manufacturers Analysis 
    6.1 GE Healthcare 
      6.1.1 Product Picture and Specification 
      6.1.2 Capacity Production Price Cost Production Value Analysis 
      6.1.3 Contact Information

    6.2 Analogic 
      6.2.1 Product Picture and Specification 
      6.2.2 Capacity Production Price Cost Production Value Analysis 
      6.2.3 Contact Information 
… 
… 
Chapter Seven North American Diagnostic Imaging Product Portfolio Industry Development Trend 
   
Part IV Europe Diagnostic Imaging Product Portfolio Industry Analysis (The Report Company Including the Below Listed But Not All)

Chapter Eight 2012-2017 Europe Diagnostic Imaging Product Portfolio Productions Supply Sales Demand Market Status and Forecast 

Chapter Nine Europe Diagnostic Imaging Product Portfolio Key Manufacturers Analysis 
    9.1 Siemens 
      9.1.1 Product Picture and Specification 
      9.1.2 Capacity Production Price Cost Production Value Analysis 
      9.1.3 Contact Information

    9.2 Philips 
      9.2.1 Product Picture and Specification 
      9.2.2 Capacity Production Price Cost Production Value Analysis 
      9.2.3 Contact Information 

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2303166

Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Study Shows MRIs Are Safe for Patients with Wide Variety of Pacemakers, Defibrillators

Magnetic resonance imaging appears to be safe for patients with cardiac implantable electronic devices, even for chest imaging, according to a new study by Utah researchers.

You would think if there was even a 1 percent chance of having a problem, it would have shown up. Not even one generator or lead needed more than a minor adjustment, if any at all.”

— Jeffrey L. Anderson, MD, Intermountain Medical Center Heart Institute

SALT LAKE CITY , UT, USA, September 29, 2017 /EINPresswire.com/ — Magnetic resonance imaging appears to be safe for patients with cardiac implantable electronic devices, even for chest imaging, according to a new study by researchers from the Intermountain Medical Center Heart Institute in Salt Lake City.

In the past, MRIs have been considered dangerous for people who have the devices. However, the new study, “Real World MRI Experience with Non-Conditional and Conditional Cardiac Rhythm Devices After MagnaSafe,” published in the Journal of Clinical Electrophysiology, found that MRI imaging can be safely performed on patients with devices.

“Magnetic resonance imaging has become very popular,” said Jeffrey L. Anderson, MD, senior study author and cardiologist at the Intermountain Medical Center Heart Institute. “It’s excellent for looking at soft tissue changes. But it involves very high-strength magnetic fields, which means if a patient has any implanted metal devices containing iron, it could potentially cause harm.”

X-rays can see bone, but they don’t provide much information about soft tissues like the brain, the heart or other internal organs. “MRIs are marvelous for that,” Dr. Anderson said.

Intermountain Medical Center Heart Institute researchers evaluated 212 MRI studies in 178 patients with a cardiac implantable electronic device between February 2014 and August 2016. They didn’t find a single problem requiring remediation in the entire series, which involved a total of 418 implanted leads.

“That’s a pretty big number of leads exposed to these very strong MRI fields. You would think if there was even a 1 percent chance of having a problem, it would have shown up,” Dr. Anderson said. “Not even one generator or lead needed more than a minor adjustment, if any at all.”

In the past, MRIs have been considered risky because of the fear a pacemaker or defibrillator device’s generator circuits could be disrupted, or its metal leads could be pulled out of place by the magnetism, or the lead tips could become hot and scar surrounding tissues, interfering with pacing and defibrillating function.

To counter that, some newer devices have been specifically made and tested to be safe for use with MRIs, under certain test conditions in magnetic fields. Devices in this category are referred to as “conditional CIEDs” (cardiac implantable electronic devices), and have been approved for MRI use under imaging conditions implemented by the U.S. Food and Drug Administration.

Most people who have implantable defibrillators and pacemakers don’t have these newer, more expensive conditional devices, however. Rather, they have standard non-conditional devices. In patients with non-conditional devices who have a medical need for imaging, and in whom MRI is deemed the most desirable diagnostic tool, MRI usually hasn’t been used, or the non-conditional devices and leads have been removed and replaced with conditional devices and leads beforehand.

Imaging decision-making for those with cardiac implantable electronic devices has started to change with publication this year of a large multicenter study called the MagnaSafe Registry study, which showed that non-conditional devices can be safely imaged by MRI, if proper precautions are observed. That study was published in the New England Journal of Medicine.

That study was limited in that it looked at safety of MRIs only in parts of the body not in direct proximity to the implantable cardiac rhythm devices, which are typically in the chest under one of the collarbones.

The new Intermountain Medical Center Heart Institute study directly builds on the MagnaSafe study, validating findings of the main MagnaSafe cohort of 1,500 patients, and expanding that group of patients to include those who need an MRI of their lungs, heart or other organs within the chest.

In addition, the new study includes many patients with conditional devices, providing a side-by-side comparison of the two types of devices.

The lead author and several of the other researchers involved in the earlier MagnaSafe trial, including Dr. Anderson, already have signed and submitted a letter to the U.S. Centers for Medicare & Medicaid Services, asking it begin to pay for medically-necessary MRIs done in patients with non-conditional devices and performed under the specially monitored situations that MagnaSafe showed to be safe.

Dr. Anderson said the new study by the Intermountain Medical Center Heart Institute team confirms the MagnaSafe findings and shows it’s also safe to use MRI to look at the heart or lungs in patients with these implantable devices.

Besides Dr. Anderson, the Intermountain Medical Center Heart Institute research team included Steve Mason, PA-C; Jeffrey S. Osborn, MD; Ritesh Dhar, MD; Allison Tonkin, MD; Jon-David Ethington, PA-C; Viet Le, MPAS, PA-C; Jose Benuzillo, PhD, MStat; Donald L. Lappé, MD; Kirk U. Knowlton, MD; and T. Jared Bunch, MD.
###

Jess Gomez
Intermountain Medical Center
801-507-7455
email us here


Source: EIN Presswire

Fish Oil Market Analysis 2017 (By Demand, Key Players and Consumption) and Forecasts To 2024

Fish Oil Market 2017 Global Analysis, Opportunities and Forecast to 2024

PUNE, INDIA, September 29, 2017 /EINPresswire.com/ — Pune, India, 29th September 2017: WiseGuyReports announced addition of new report, titled “Global Fish Oil Market Outlook 2024: Global Opportunity and Demand Analysis, Market Forecast, 2016-2024”.

Market Overview
Food supplement are very common in present generation as it help in filling up a deficiency in diet of individuals. Due to high volume of long chain omega 3 fatty acid fish oil is used as food supplement. Increase in number of food supplement is making the fish oil market bigger.
Fish oil market help in healing the wide range of syndrome that includes ulcer, immune disorder, cancer, diabetes etc. Fish oil is on the fundamental peak as the growth of aquaculture will also give a rise to growth of fish oil market. Fish oil is also widely used in some of the cosmetic product in the form of emollient which is utilized to soften the skin and used as general ointment as well.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2316607-global-fish-oil-market-outlook-2024-global-opportunity-and-demand-analysis

The change in eating habits of people which gives rise to hydrogenated oil is expected to imitate the expansion of industry. Notwithstanding the facts that high cost of products are restraining the growth of fish oil market.

Key Players
• TASA
o Synopsis
o Business Strategy
o Product Portfolio
o SWOT Analysis
• Omega Protein Corporation
• Copeinca AS
• Corpesca SA
• FMC Corporation
• TripleNine
• Pesquera Diamante S.A
• Marvesa Holding N.V.
• Pesquera Exalmar
• FF Skagen A/S
• Colpex internation
• MArvesa
• Nordic naturals
• Nutrifynn Caps

Market Segmentation
• By Source
o Salmon & trout
o Marine fish
o Crustaceans
o Tilapias
o Carps
• By Application
o Livestock
 Aquatic animals
 Swine
 Poultry
 Cattle
 Pets
o Industrial
 Fertilizer
 Aquaculture
 Pharmaceuticals

• By Region
o North America (US, Canada) {Market Share (%), Market Size (USD Million), Consumption Rate (%)}
o Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Million), Consumption Rate (%)}
o Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Million), Consumption Rate (%)}
o Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Million), Consumption Rate (%)}
o Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Million), Consumption Rate (%)}
o Rest of the World {Market Share (%), Market Size (USD Million), Consumption Rate (%)}

Market Size and Forecast (2016-2024)
The emerging market of fish oil goes on increasing year after year that has reached USD 2.50 billion in 2016 and is predicted to reach USD 4.50 billion by 2024 at a CAGR of approximately 6% in forecast period 2016-2024.
On the basis of industrial application rising stock of breeding in aquaculture dominated the market during the period 2016 and will tend to dominate the market till 7-8 years.
In terms of region, Europe is said to have the largest share and holds approximately 48% of fish oil market during 2016 followed by North America and APAC. The Europe fish oil market dominates due to hard establishment of aquaculture and fisheries in countries such as Denmark and Northern Europe.
The market of Europe is known for its high quality and standard product of aquaculture. In APAC, China is the biggest contributor of fish oil market due to increasing aquaculture industry.

Key Trends and Growth Drivers
The market of fish oil has various factors that lead the market towards growth. They are:
 Rising business of deep rooted disease provides awareness to omega 3 fish oil which is used as supplement to prevent certain chronic disease.
 Assist in weight loss and provides an aid during pregnancy.
 Recommendation by government for healthy intake of fatty acid.
Restraints
The factors that hamper the growth of fish oil market are:
 Sometimes there may be reduced or unchanged production in fish oil which may hamper the growth of the market
 Also the frequency and climatic changes sometime provides a gap between demand and actual harvest of fish.

…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2316607-global-fish-oil-market-outlook-2024-global-opportunity-and-demand-analysis

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire